Trademark: 97764174
Word
BIOLINQ
Status Date
Wednesday, August 14, 2024
Filing Date
Monday, January 23, 2023
9 Downloadable software used with wearable sensors for monitoring blood glucose and managing diabetes; downloadable mobile application software used with wearable sensors for monitoring blood glucose and managing diabetes; none of the foregoing relating to incontinence or geriatric care
The mark consists of the word "BIOLINQ" in lower case, fanciful font.
Color is not claimed as a feature of the mark.
Feb 12, 2023
New Application Office Supplied Data Entered
Jan 26, 2023
New Application Entered
Sep 22, 2023
Assigned To Examiner
Sep 23, 2023
Non-Final Action Written
Sep 23, 2023
Non-Final Action E-Mailed
Sep 23, 2023
Notification Of Non-Final Action E-Mailed
Dec 26, 2023
Teas Response To Office Action Received
Dec 26, 2023
Correspondence Received In Law Office
Dec 27, 2023
Teas/Email Correspondence Entered
Aug 14, 2024
Final Refusal Written
Aug 14, 2024
Notification Of Final Refusal Emailed
Aug 14, 2024
Final Refusal E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24